Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports binding to enzyme active sites, enhancing drug efficacy. Also employed in agrochemicals to improve the stability and activity of crop protection agents. The trifluoromethyl group contributes to increased metabolic stability and lipophilicity, making it valuable in optimizing pharmacokinetic properties of active compounds.